These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1832972)

  • 21. Clomipramine, clonazepam, and clonidine treatment of obsessive-compulsive disorder.
    Hewlett WA; Vinogradov S; Agras WS
    J Clin Psychopharmacol; 1992 Dec; 12(6):420-30. PubMed ID: 1474179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blind study of adjuvant buspirone hydrochloride in clomipramine-treated patients with obsessive-compulsive disorder.
    Pigott TA; L'Heureux F; Hill JL; Bihari K; Bernstein SE; Murphy DL
    J Clin Psychopharmacol; 1992 Feb; 12(1):11-8. PubMed ID: 1552034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial.
    Thorén P; Asberg M; Cronholm B; Jörnestedt L; Träskman L
    Arch Gen Psychiatry; 1980 Nov; 37(11):1281-5. PubMed ID: 7436690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous clomipramine for obsessive-compulsive disorder refractory to oral clomipramine: a placebo-controlled study.
    Fallon BA; Liebowitz MR; Campeas R; Schneier FR; Marshall R; Davies S; Goetz D; Klein DF
    Arch Gen Psychiatry; 1998 Oct; 55(10):918-24. PubMed ID: 9783563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder.
    Foa EB; Liebowitz MR; Kozak MJ; Davies S; Campeas R; Franklin ME; Huppert JD; Kjernisted K; Rowan V; Schmidt AB; Simpson HB; Tu X
    Am J Psychiatry; 2005 Jan; 162(1):151-61. PubMed ID: 15625214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A clomipramine dosage reduction study in the course of long-term treatment of obsessive-compulsive disorder patients.
    Pato MT; Hill JL; Murphy DL
    Psychopharmacol Bull; 1990; 26(2):211-4. PubMed ID: 2236458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of obsessive-compulsive symptoms in schizophrenic patients with clomipramine.
    Berman I; Sapers BL; Chang HH; Losonczy MF; Schmildler J; Green AI
    J Clin Psychopharmacol; 1995 Jun; 15(3):206-10. PubMed ID: 7635998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study.
    Flament MF; Rapoport JL; Berg CJ; Sceery W; Kilts C; Mellström B; Linnoila M
    Arch Gen Psychiatry; 1985 Oct; 42(10):977-83. PubMed ID: 3899048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New pharmacologic approaches to obsessive compulsive disorder.
    Insel TR
    J Clin Psychiatry; 1990 Oct; 51 Suppl():47-51; discussion 56-8. PubMed ID: 2120204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of adolescent obsessive-compulsive disorder with a clomipramine-fluoxetine combination.
    Simeon JG; Thatte S; Wiggins D
    Psychopharmacol Bull; 1990; 26(3):285-90. PubMed ID: 2274627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clomipramine and obsessive compulsive disorder: a placebo-controlled double-blind study of 32 patients.
    Greist JH; Jefferson JW; Rosenfeld R; Gutzmann LD; March JS; Barklage NE
    J Clin Psychiatry; 1990 Jul; 51(7):292-7. PubMed ID: 2195006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiobsessional and antidepressant effects of clomipramine in the treatment of obsessive-compulsive disorder.
    Insel TR; Alterman I; Murphy DL
    Psychopharmacol Bull; 1982 Oct; 18(4):115-7. PubMed ID: 7156271
    [No Abstract]   [Full Text] [Related]  

  • 33. Obsessive-compulsive disorder: a double-blind, placebo-controlled trial of clomipramine in 27 patients.
    Jenike MA; Baer L; Summergrad P; Weilburg JB; Holland A; Seymour R
    Am J Psychiatry; 1989 Oct; 146(10):1328-30. PubMed ID: 2675643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical predictors of treatment response in obsessive compulsive disorder: exploratory analyses from multicenter trials of clomipramine.
    DeVeaugh-Geiss J; Katz R; Landau P; Goodman W; Rasmussen S
    Psychopharmacol Bull; 1990; 26(1):54-9. PubMed ID: 2196627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preliminary results from a multicenter trial of clomipramine in obsessive-compulsive disorder.
    DeVeaugh-Geiss J; Landau P; Katz R
    Psychopharmacol Bull; 1989; 25(1):36-40. PubMed ID: 2672070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolactin in childhood obsessive-compulsive disorder: clinical correlates and response to clomipramine.
    Hanna GL; McCracken JT; Cantwell DP
    J Am Acad Child Adolesc Psychiatry; 1991 Mar; 30(2):173-8. PubMed ID: 2016218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder.
    Pato MT; Zohar-Kadouch R; Zohar J; Murphy DL
    Am J Psychiatry; 1988 Dec; 145(12):1521-5. PubMed ID: 3057923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clomipramine in obsessive-compulsive disorder. Further evidence for a serotonergic mechanism of action.
    Benkelfat C; Murphy DL; Zohar J; Hill JL; Grover G; Insel TR
    Arch Gen Psychiatry; 1989 Jan; 46(1):23-8. PubMed ID: 2910220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controlled comparison of buspirone and clomipramine in obsessive-compulsive disorder.
    Pato MT; Pigott TA; Hill JL; Grover GN; Bernstein S; Murphy DL
    Am J Psychiatry; 1991 Jan; 148(1):127-9. PubMed ID: 1984696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obsessive-compulsive disorder as a 5-HT subsystem-related behavioural disorder.
    Murphy DL; Zohar J; Benkelfat C; Pato MT; Pigott TA; Insel TR
    Br J Psychiatry Suppl; 1989 Dec; (8):15-24. PubMed ID: 2692636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.